ID   EDA_HUMAN      STANDARD;      PRT;   391 AA.
AC   Q92838; O75910; Q9UP77; Q9Y6L0; Q9Y6L1; Q9Y6L2; Q9Y6L3; Q9Y6L4;
DT   01-NOV-1997 (Rel. 35, Created)
DT   15-JUL-1999 (Rel. 38, Last sequence update)
DT   10-OCT-2003 (Rel. 42, Last annotation update)
DE   Ectodysplasin A (Ectodermal dysplasia protein) (EDA protein).
GN   ED1 OR EDA.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   SEQUENCE FROM N.A. (ISOFORM I), AND VARIANTS EDA HIS-61 AND LEU-69.
RC   TISSUE=Sweat gland;
RX   MEDLINE=96331280; PubMed=8696334;
RA   Kere J., Srivastava A.K., Montonen O., Zonana J., Thomas N.S.T.,
RA   Ferguson B.M., Munoz F., Morgan D., Clarke A., Baybayan P.,
RA   Chen E.Y., Ezer S., Saarialho-Kere U., la Chapelle A.,
RA   Schlessinger D.;
RT   "X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by
RT   mutation in a novel transmembrane protein.";
RL   Nat. Genet. 13:409-416(1996).
RN   [2]
RP   SEQUENCE FROM N.A. (ISOFORM A1), AND VARIANTS EDA.
RC   TISSUE=Liver;
RX   MEDLINE=98349961; PubMed=9683615;
RA   Monreal A.W., Zonana J., Ferguson B.M.;
RT   "Identification of a new splice form of the EDA1 gene permits
RT   detection of nearly all X-linked hypohidrotic ectodermal dysplasia
RT   mutations.";
RL   Am. J. Hum. Genet. 63:380-389(1998).
RN   [3]
RP   SEQUENCE FROM N.A. (ISOFORMS A1; A2; B; C; D; E AND F), AND VARIANTS
RP   EDA.
RX   MEDLINE=98409495; PubMed=9736768;
RA   Bayes M., Hartung A.J., Ezer S., Pispa J., Thesleff I.,
RA   Srivastava A.K., Kere J.;
RT   "The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative
RT   splicing and encodes ectodysplasin-A with deletion mutations in
RT   collagenous repeats.";
RL   Hum. Mol. Genet. 7:1661-1669(1998).
RN   [4]
RP   SEQUENCE FROM N.A. (ISOFORMS A1 AND C).
RA   Clark S.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RA   Kobielak K., Kobielak A., Trzciak W.H.;
RT   "Expression of a novel transcript isoform of the EDA gene in human
RT   umbilical cord.";
RL   Eur. J. Hum. Genet. Suppl. 7:104-104(1999).
RN   [6]
RP   RECEPTOR INTERACTION (ISOFORMS A1 AND A2).
RX   MEDLINE=20495245; PubMed=11039935;
RA   Yan M., Wang L.-C., Hymowitz S.G., Schilbach S., Lee J., Goddard A.,
RA   de Vos A.M., Gao W.-Q., Dixit V.M.;
RT   "Two-amino acid molecular switch in an epithelial morphogen that
RT   regulates binding to two distinct receptors.";
RL   Science 290:523-527(2000).
RN   [7]
RP   PROCESSING, MUTAGENESIS OF ARG-153, AND CHARACTERIZATION OF VARIANT
RP   HIS-156.
RX   MEDLINE=21205766; PubMed=11309369;
RA   Elomaa O., Pulkkinen K., Hannelius U., Mikkola M., Saarialho-Kere U.,
RA   Kere J.;
RT   "Ectodysplasin is released by proteolytic shedding and binds to the
RT   EDAR protein.";
RL   Hum. Mol. Genet. 10:953-962(2001).
RN   [8]
RP   CHARACTERIZATION OF VARIANTS CYS-155; CYS-156 AND HIS-156, MUTAGENESIS
RP   OF ARG-153; LYS-158 AND ARG-159, AND CLEAVAGE SITE.
RX   MEDLINE=21309995; PubMed=11416205;
RA   Chen Y., Molloy S.S., Thomas L., Gambee J., Baechinger H.P.,
RA   Ferguson B.M., Zonana J., Thomas G., Morris N.P.;
RT   "Mutations within a furin consensus sequence block proteolytic release
RT   of ectodysplasin-A and cause X-linked hypohidrotic ectodermal
RT   dysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7218-7223(2001).
RN   [9]
RP   VARIANT EDA TYR-54.
RX   MEDLINE=98292028; PubMed=9630076;
RA   Hertz J.M., Noergaard Hansen K., Juncker I., Kjeldsen M.,
RA   Gregersen N.;
RT   "A novel missense mutation (402C-->T) in exon 1 in the EDA gene in a
RT   family with X-linked hypohidrotic ectodermal dysplasia.";
RL   Clin. Genet. 53:205-209(1998).
RN   [10]
RP   VARIANT EDA LYS-63.
RX   MEDLINE=98168231; PubMed=9507389;
RA   Ferguson B.M., Thomas N.S.T., Munoz F., Morgan D., Clarke A.,
RA   Zonana J.;
RT   "Scarcity of mutations detected in families with X linked hypohidrotic
RT   ectodermal dysplasia: diagnostic implications.";
RL   J. Med. Genet. 35:112-115(1998).
RN   [11]
RP   VARIANT EDA ARG-55.
RX   MEDLINE=99399307; PubMed=10469321;
RA   Martinez F., Millan J.M., Orellana C., Prieto F.;
RT   "X-linked anhidrotic (hypohidrotic) ectodermal dysplasia caused by a
RT   novel mutation in EDA1 gene: 406T > G (Leu55Arg).";
RL   J. Invest. Dermatol. 113:285-286(1999).
RN   [12]
RP   VARIANTS EDA ARG-60; TYR-252; VAL-269; SER-302 AND MET-378.
RX   MEDLINE=21272350; PubMed=11378824;
RA   Vincent M.C., Biancalana V., Ginisty D., Mandel J.L., Calvas P.;
RT   "Mutational spectrum of the ED1 gene in X-linked hypohidrotic
RT   ectodermal dysplasia.";
RL   Eur. J. Hum. Genet. 9:355-363(2001).
RN   [13]
RP   VARIANTS EDA CYS-156; HIS-156; CYS-255; ASP-255; GLY-274; TYR-332 AND
RP   THR-349.
RX   MEDLINE=21193173; PubMed=11295832;
RA   Paeaekkoenen K., Cambiaghi S., Novelli G., Ouzts L.V., Penttinen M.,
RA   Kere J., Srivastava A.K.;
RT   "The mutation spectrum of the EDA gene in X-linked anhidrotic
RT   ectodermal dysplasia.";
RL   Hum. Mutat. 17:349-349(2001).
CC   -!- FUNCTION: Seems to be involved in epithelial-mesenchymal signaling
CC       during morphogenesis of ectodermal organs. Isoform A1 binds only
CC       to the receptor EDAR, while isoform A2 binds exclusively to the
CC       receptor XEDAR.
CC   -!- SUBUNIT: Homotrimer.
CC   -!- SUBCELLULAR LOCATION: Type II membrane protein and secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist;
CC       Name=A1; Synonyms=II;
CC         IsoId=Q92838-1; Sequence=Displayed;
CC       Name=I;
CC         IsoId=Q92838-2; Sequence=VSP_006454, VSP_006455;
CC       Name=A2;
CC         IsoId=Q92838-3; Sequence=VSP_006464;
CC       Name=B;
CC         IsoId=Q92838-4; Sequence=VSP_006462, VSP_006463;
CC       Name=C;
CC         IsoId=Q92838-5; Sequence=VSP_006458, VSP_006461;
CC       Name=D;
CC         IsoId=Q92838-6; Sequence=VSP_006456, VSP_006457;
CC       Name=E;
CC         IsoId=Q92838-7; Sequence=VSP_006459, VSP_006461;
CC       Name=F;
CC         IsoId=Q92838-8; Sequence=VSP_006460, VSP_006461;
CC   -!- TISSUE SPECIFICITY: Not abundant; expressed in specific cell types
CC       of ectodermal (but not mesodermal) origin of keratinocytes, hair
CC       follicles, sweat glands. Also in adult heart, liver, muscle,
CC       pancreas, prostate, fetal liver, uterus, small intestine and
CC       umbilical chord.
CC   -!- PTM: N-glycosylated.
CC   -!- PTM: Processing by furin produces a secreted form.
CC   -!- DISEASE: Defects in ED1 are the cause of ectodermal dysplasia,
CC       anhidrotic (EDA) [MIM:305100]; also known as X-linked hypohidrotic
CC       ectodermal dysplasia (XLHED). EDA is a disease characterized by
CC       sparse hair (atrichosis or hypotrichosis), abnormal or missing
CC       teeth and the inability to sweat due to the absence of sweat
CC       glands. EDA is the most common form of over 150 clinically
CC       distinct ectodermal dysplasias. This disease was already described
CC       by Darwin.
CC   -!- SIMILARITY: Belongs to the tumor necrosis factor family.
CC   -!- SIMILARITY: Contains 1 collagenous domain.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U59227; AAC50678.1; -.
DR   EMBL; U59228; AAC50679.1; -.
DR   EMBL; AF061189; AAC77371.1; -.
DR   EMBL; AF061190; AAC77372.1; -.
DR   EMBL; AF061191; AAC77373.1; -.
DR   EMBL; AF061192; AAC77374.1; -.
DR   EMBL; AF061193; AAC77375.1; -.
DR   EMBL; AF061194; AAC77376.1; -.
DR   EMBL; AF060999; AAC36302.1; -.
DR   EMBL; AF060998; AAC36303.1; -.
DR   EMBL; AF060992; AAC36303.1; JOINED.
DR   EMBL; AF060993; AAC36303.1; JOINED.
DR   EMBL; AF060994; AAC36303.1; JOINED.
DR   EMBL; AF060995; AAC36303.1; JOINED.
DR   EMBL; AF060996; AAC36303.1; JOINED.
DR   EMBL; AF060997; AAC36303.1; JOINED.
DR   EMBL; AF040628; AAC77363.1; -.
DR   EMBL; AL158069; CAD18890.1; -.
DR   EMBL; AL158141; CAD13493.1; -.
DR   Genew; HGNC:3157; ED1.
DR   MIM; 300451; -.
DR   MIM; 305100; -.
DR   GO; GO:0005856; C:cytoskeleton; TAS.
DR   GO; GO:0016021; C:integral to membrane; TAS.
DR   GO; GO:0005624; C:membrane fraction; TAS.
DR   GO; GO:0005886; C:plasma membrane; TAS.
DR   GO; GO:0005102; F:receptor binding; TAS.
DR   GO; GO:0007398; P:ectoderm development; TAS.
DR   GO; GO:0007165; P:signal transduction; TAS.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR006052; TNF_family.
DR   InterPro; IPR008983; TNF_like.
DR   Pfam; PF01391; Collagen; 1.
DR   SMART; SM00207; TNF; 1.
DR   PROSITE; PS00251; TNF_1; FALSE_NEG.
DR   PROSITE; PS50049; TNF_2; 1.
KW   Differentiation; Developmental protein; Signal-anchor; Transmembrane;
KW   Collagen; Glycoprotein; Alternative splicing; Disease mutation;
KW   Anhidrotic ectodermal dysplasia.
FT   CHAIN         1    391       ECTODYSPLASIN A, MEMBRANE FORM.
FT   CHAIN       160    391       ECTODYSPLASIN A, SECRETED FORM.
FT   DOMAIN        1     41       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM     42     62       SIGNAL-ANCHOR (TYPE-II MEMBRANE PROTEIN)
FT                                (POTENTIAL).
FT   DOMAIN       63    391       EXTRACELLULAR (POTENTIAL).
FT   DOMAIN      180    229       COLLAGEN-LIKE.
FT   SITE        159    160       CLEAVAGE (BY FURIN).
FT   CARBOHYD    313    313       N-LINKED (GLCNAC...) (POTENTIAL).
FT   CARBOHYD    372    372       N-LINKED (GLCNAC...) (POTENTIAL).
FT   VARSPLIC    133    135       MAL -> GHQ (in isoform I).
FT                                /FTId=VSP_006454.
FT   VARSPLIC    136    391       Missing (in isoform I).
FT                                /FTId=VSP_006455.
FT   VARSPLIC    133    142       MALLNFFFPD -> ACFPQVLLSL (in isoform D).
FT                                /FTId=VSP_006456.
FT   VARSPLIC    143    391       Missing (in isoform D).
FT                                /FTId=VSP_006457.
FT   VARSPLIC    133    147       MALLNFFFPDEKPYS -> VSHLVGAAAAPSPRG (in
FT                                isoform C).
FT                                /FTId=VSP_006458.
FT   VARSPLIC    133    147       MALLNFFFPDEKPYS -> DFDYIISFSYGLQGFC (in
FT                                isoform E).
FT                                /FTId=VSP_006459.
FT   VARSPLIC    133    147       MALLNFFFPDEKPYS -> LHVSFSLRKKKAGHQ (in
FT                                isoform F).
FT                                /FTId=VSP_006460.
FT   VARSPLIC    148    391       Missing (in isoform C, isoform E and
FT                                isoform F).
FT                                /FTId=VSP_006461.
FT   VARSPLIC    169    178       PVKNKKKGKK -> KSTQLILYHF (in isoform B).
FT                                /FTId=VSP_006462.
FT   VARSPLIC    179    391       Missing (in isoform B).
FT                                /FTId=VSP_006463.
FT   VARSPLIC    307    308       Missing (in isoform A2).
FT                                /FTId=VSP_006464.
FT   VARIANT      54     54       H -> Y (in EDA).
FT                                /FTId=VAR_010611.
FT   VARIANT      55     55       L -> R (in EDA).
FT                                /FTId=VAR_010612.
FT   VARIANT      60     60       C -> R (in EDA).
FT                                /FTId=VAR_013484.
FT   VARIANT      61     61       Y -> H (in EDA).
FT                                /FTId=VAR_005179.
FT   VARIANT      63     63       E -> K (in EDA).
FT                                /FTId=VAR_005180.
FT   VARIANT      69     69       R -> L (in EDA).
FT                                /FTId=VAR_005181.
FT   VARIANT     155    155       R -> C (in EDA; abolishes proteolytic
FT                                processing).
FT                                /FTId=VAR_005182.
FT   VARIANT     156    156       R -> C (in EDA; abolishes proteolytic
FT                                processing).
FT                                /FTId=VAR_005183.
FT   VARIANT     156    156       R -> H (in EDA; abolishes proteolytic
FT                                processing).
FT                                /FTId=VAR_005184.
FT   VARIANT     209    209       P -> L (in EDA).
FT                                /FTId=VAR_005185.
FT   VARIANT     224    224       G -> A (in EDA).
FT                                /FTId=VAR_005186.
FT   VARIANT     252    252       H -> L (in EDA).
FT                                /FTId=VAR_005187.
FT   VARIANT     252    252       H -> Y (in EDA).
FT                                /FTId=VAR_013485.
FT   VARIANT     255    255       G -> C (in EDA).
FT                                /FTId=VAR_011077.
FT   VARIANT     255    255       G -> D (in EDA; mild).
FT                                /FTId=VAR_011078.
FT   VARIANT     269    269       G -> V (in EDA).
FT                                /FTId=VAR_013486.
FT   VARIANT     274    274       W -> G (in EDA).
FT                                /FTId=VAR_011079.
FT   VARIANT     291    291       G -> R (in EDA).
FT                                /FTId=VAR_010613.
FT   VARIANT     291    291       G -> W (in EDA).
FT                                /FTId=VAR_010614.
FT   VARIANT     298    298       D -> H (in EDA).
FT                                /FTId=VAR_010615.
FT   VARIANT     299    299       G -> S (in EDA).
FT                                /FTId=VAR_005188.
FT   VARIANT     302    302       F -> S (in EDA).
FT                                /FTId=VAR_013487.
FT   VARIANT     332    332       C -> Y (in EDA).
FT                                /FTId=VAR_011080.
FT   VARIANT     349    349       A -> T (in EDA).
FT                                /FTId=VAR_005189.
FT   VARIANT     356    356       A -> D (in EDA).
FT                                /FTId=VAR_005190.
FT   VARIANT     357    357       R -> P (in EDA).
FT                                /FTId=VAR_005191.
FT   VARIANT     378    378       T -> M (in EDA).
FT                                /FTId=VAR_013488.
FT   MUTAGEN     153    153       R->C: ABOLISHES PROTEOLYTIC PROCESSING.
FT   MUTAGEN     158    158       K->N: ABOLISHES PROTEOLYTIC PROCESSING.
FT   MUTAGEN     159    159       R->A: ABOLISHES PROTEOLYTIC PROCESSING.
SQ   SEQUENCE   391 AA;  41294 MW;  15DB3F5053293CBA CRC64;
     MGYPEVERRE LLPAAAPRER GSQGCGCGGA PARAGEGNSC LLFLGFFGLS LALHLLTLCC
     YLELRSELRR ERGAESRLGG SGTPGTSGTL SSLGGLDPDS PITSHLGQPS PKQQPLEPGE
     AALHSDSQDG HQMALLNFFF PDEKPYSEEE SRRVRRNKRS KSNEGADGPV KNKKKGKKAG
     PPGPNGPPGP PGPPGPQGPP GIPGIPGIPG TTVMGPPGPP GPPGPQGPPG LQGPSGAADK
     AGTRENQPAV VHLQGQGSAI QVKNDLSGGV LNDWSRITMN PKVFKLHPRS GELEVLVDGT
     YFIYSQVEVY YINFTDFASY EVVVDEKPFL QCTRSIETGK TNYNTCYTAG VCLLKARQKI
     AVKMVHADIS INMSKHTTFF GAIRLGEAPA S
//
